openPR Logo
Press release

Treatment Syndromes Dementia Movement Disorders Marketis Worth USD 21,154.8 Mn By 2020

10-10-2017 11:44 AM CET | Health & Medicine

Press release from: Persistence Market Research

Treatment Syndromes Dementia Movement Disorders Marketis

According to a new market report published by Persistence Market Research “Global Market Study on Treatment for Syndromes of Dementia and Movement Disorders: Asia to Witness Highest Growth by 2020,” the global treatment for syndromes of dementia and movement disorders market was valued at USD 12,859.8 million in 2014 and is expected to grow at a CAGR of 8.6% from 2014 to 2020, to reach an estimated value of USD 21,154.8 million in 2020.

Request to view table of content @ https://www.persistencemarketresearch.com/market-research/treatment-syndromes-dementia-movement-disorders-market/toc

The treatment for syndromes of dementia and movement disorders market is witnessing significant growth due to increasing R&D investments in drug discovery and developments. In addition, increasing prevalence of neurodegenerative disorders and rising awareness about mental disorders are also driving the growth of the market. However, most of the drugs fail in Phase III due to lack of sufficient knowledge about the mechanisms of the brain and the unknown causes of the disease.

In addition, lack of comprehensive therapeutic management, strict regulations, and time-consuming drug approval process inhibit the growth of the market. The global treatment for syndromes of dementia and movement disorders market is anticipated to grow from an estimated USD 12,859.8 million in 2014 to USD 21,154.8 million in 2020 at a CAGR of 8.6% during the forecast period.

A sample of this report is available upon request @ https://www.persistencemarketresearch.com/samples/2833

In North America, growing aging population and rising incidence of neurodegenerative disease are driving the use of treatment for syndromes of dementia and movement disorders in the market. In addition, lack of proper medication is also fuelling the growth of treatments for syndromes of dementia and movement disorders market.

In Europe, the treatment for syndromes of dementia and movement disorders market is driven by rising incidence of mental disorder related disease and growing aging population. On the other hand, various awareness programs were launched by public and private health institutions to control dementia and movement disorders, which would increase the use of dementia and movement disorder drugs in the region.

Browse Complete Report @ https://www.persistencemarketresearch.com/market-research/treatment-syndromes-dementia-movement-disorders-market.asp

However, in Asia the growth for treatment for syndromes of dementia and movement disorders is much higher than developed countries due to widening health insurance penetration, and large population base.

F. Hoffmann-La Roche, Ltd., Novartis AG, Merck & Co., Inc., Sanofi S.A., Valeant Pharmaceutical International, Inc., AstraZeneca GmbH and Pfizer, Inc. are some of the major players of treatment for syndromes of dementia and movement disorders market.

Global Market Study on Syndromes of Dementia and Movement Disorders Market is available at $4900 @ https://www.persistencemarketresearch.com/checkout/2833

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Treatment Syndromes Dementia Movement Disorders Marketis Worth USD 21,154.8 Mn By 2020 here

News-ID: 764966 • Views:

More Releases from Persistence Market Research

Anime Market Set to Grow Significantly, Reaching USD 54.1 Billion by 2031 Amid Rising Global Popularity
Anime Market Set to Grow Significantly, Reaching USD 54.1 Billion by 2031 Amid R …
The global anime market has evolved far beyond traditional television broadcasts to become a multifaceted entertainment ecosystem. Driven by digital transformation, streaming services, and cross-media collaborations, anime has expanded its footprint globally, appealing to diverse audiences across age groups. Anime now extends into gaming, merchandising, licensing, and international film distribution, creating multiple revenue streams beyond conventional formats. According to market projections, the anime market is expected to grow from US$31.9 billion
Artificial Intelligence as a Service Market Forecasted to Grow at 34.6% CAGR, Reaching USD 82.4 Billion by 2031
Artificial Intelligence as a Service Market Forecasted to Grow at 34.6% CAGR, Re …
The Artificial Intelligence as a Service (AIaaS) market has emerged as one of the most transformative segments in the global technology ecosystem. By providing AI capabilities on a subscription or pay-per-use model, AIaaS allows organizations to deploy advanced AI functionalities without the need for significant in-house infrastructure. This model has democratized access to AI, enabling small and medium-sized enterprises to leverage predictive analytics, natural language processing, and machine learning tools
Server Operating System Market Anticipated to Witness Robust Growth, Reaching USD 34.5 Billion by 2031
Server Operating System Market Anticipated to Witness Robust Growth, Reaching US …
The server operating system market is witnessing robust growth, driven by the rapid expansion of data centers and the surging adoption of cloud technologies across enterprises worldwide. Server operating systems form the backbone of modern IT infrastructure, enabling organizations to efficiently manage hardware resources, deploy applications, and maintain high levels of system reliability and security. As businesses increasingly migrate to cloud environments and data-intensive operations grow, demand for powerful, scalable,
Manufacturing Operations Management Software Industry Anticipated to Witness Rapid Growth, Reaching USD 69.8 Billion by 2032
Manufacturing Operations Management Software Industry Anticipated to Witness Rap …
The Manufacturing Operations Management (MOM) software market is rapidly emerging as a cornerstone of digital transformation in the manufacturing sector. As industries increasingly adopt Industry 4.0 practices, the need for advanced solutions that integrate production planning, real-time monitoring, quality control, and process optimization has surged. MOM software enables manufacturers to streamline operations, reduce production downtime, and improve overall efficiency, making it an indispensable tool across automotive, pharmaceutical, aerospace, and consumer

All 5 Releases


More Releases for Syndromes

Cryopyrin-Associated Periodic Syndromes (CAPS) Market Trends, Treatment Landscap …
Cryopyrin-Associated Periodic Syndromes (CAPS) represent a rare group of autoinflammatory disorders driven by genetic mutations in the NLRP3 gene, leading to excessive production of interleukin-1β (IL-1β). Though the global prevalence is limited, growing awareness, diagnostic advancements, and expanding availability of targeted biologic therapies have created a defined commercial opportunity. Pharmaceutical companies, healthcare institutions, and research organizations are focusing on novel therapeutic approaches, thereby fueling growth prospects of the CAPS market
Malabsorption Syndromes Market is Going to Hit at CAGR of 5.45% by 2028
A steadfast Malabsorption Syndromes market research report is organized by collecting market research data from different corners of the globe with an experienced team of language resources. Keeping in mind the customer requirement, this finest market research report is constructed with the professional and in-depth study of Healthcare industry. As market research reports are gaining immense importance in this swiftly transforming market place, Malabsorption Syndromes market report has been created
Global Treatment Syndromes Dementia Movement Disorders Market Size, Status And F …
According to a new market report published by Persistence Market Research "Global Market Study on Treatment for Syndromes of Dementia and Movement Disorders: Asia to Witness Highest Growth by 2020," the global treatment for syndromes of dementia and movement disorders market was valued at USD 12,859.8 million in 2014 and is expected to grow at a CAGR of 8.6% from 2014 to 2020, to reach an estimated value of USD
Treatment Syndromes Dementia Movement Disorders Market Survey and Forecast Repor …
AI-backed computer algorithms (more of sophisticated algorithms), better known as chatbots, are capable of conducting meaningful conversations (human-like) through option-based, textual, or voice-based input. The basic advantage of these chatbots would be smooth sailing on the part of patients in spite healthcare personnel being out of reach at times (due to factors like non-operation hours, disaster-induced overloads over the calls, and likewise). This would result in cutting down on long
At-home diagnostics to catalyse the Treatment Syndromes Dementia Movement Disord …
The Treatment Syndromes Dementia Movement Disorders Market is bound to grow at a remarkable rate in the forecast period. Vital Sign monitoring, in combination with wearables, does aid in symptoms check-in as well as education 24/7. There are also hand-held dongles being made available for attaching to smartphones to measure biomarkers for chronic ailments. This monitoring proves to be more cost-effective and convenient in comparison with in-person care. This trend
Myeloidysplastic Syndromes (MDS) – Epidemiology Insights (2016-2028)
Myeloidysplastic syndromes (MDS) can be described as a group of hematologic malignancies, that occurr due to abnormality in blood-forming cells in the bone marrow. It is a rare blood cancer and can be mild, moderate or severe, in terms of severity. Download the sample report @ https://www.pharmaproff.com/request-sample/1162 This syndrome can be classified into three main types: MDS with single lineage dysplasia wherein a single type of blood cell appears abnormal; multilineage